Clinical Trial Detail

NCT ID NCT03970382
Title A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors PACT Pharma, Inc.
Indications

prostate cancer

ovarian cancer

breast cancer

colorectal cancer

melanoma

transitional cell carcinoma

Therapies

NeoTCR-P1 T-cells + Nivolumab

NeoTCR-P1 T-cells

Age Groups: adult senior

No variant requirements are available.